Ozempic Copies to Cost $14 in India as Generic GLP-1 Era Starts
2026-03-20 - 07:10
(Bloomberg) — At least a dozen large drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs in India, crashing prices as soon as the patent expires Friday. Read More
Share this post: